DOBI MEDICAL INTERNATIONAL STRENGTHENS
Industry Veterans, Vascular Surgeon, Other Industry Execs Join
Mahwah, NJ, March 31, 2004 DOBI Medical International, Inc. (DBMI.OB) announced today that a number of new senior executives have been added to the senior management group of the Company. These new executives position the Company for sustained growth and accomplishment in the months ahead.
Commenting on the expansion of the senior management team, DOBI Medical International President and CEO Phillip C. Thomas said, It is exciting to assemble such an experienced, knowledgeable, and motivated group of senior managers. When you combine these new arrivals with the current members of the senior management team, we have the full range of senior management experience and talent we need to successfully carry out our plans for expansion during 2004 and beyond.
The following individuals have been appointed
to their respective positions.
Angelo Secci, MD is Vice President, Clinical Research. Dr. Secci has worked in clinical development for the past 10 years in various university, biotechnology, and pharmaceutical industry settings. Prior to joining DOBI Medical International, Dr. Secci served as Senior Associate Director, Clinical Development at Berlex Laboratories in the field of angiogenesis for the treatment of cardiovascular disease. Previously, he served as Senior Clinical Scientist at Pfizer where he was also involved in the development of an angiogenic product for the treatment of cardiovascular disease. Before joining the pharmaceutical industry, Dr. Secci served as Research Associate and Technical Director at the South Bay Heart Watch, at the Torrance UCLA Medical Center, where he participated in clinical research projects in the fields of coronary calcium imaging and cardiovascular disease. Dr. Secci received his degree in medicine and surgery from the University of Rome La Sapienza Italy. Dr. Secci is responsible for all clinical research activities and serves as the Companys medical interface to the FDA.
Bob Sohval, PhD is Vice President, Research and Development. Dr. Sohval has worked in the diagnostic imaging industry for more than 25 years and has held executive leadership positions in several private and public companies. Dr. Sohval has been involved in system design and product development of innovative digital radiography detectors, advanced breast imaging systems, high performance CT scanners, and holds nine patents in medical imaging. He has a BS and PhD in Physics, both from M.I.T., and has completed the Advanced Management Program at the Harvard Business School. As senior technologist, Bob will lead the Companys efforts to complete the current development for the ComfortScan system and continue efforts on next generation versions.
Sal A. Lucia has
been named Director of Operations. Mr. Lucia has over 20 years of operational
experience in the medical imaging and capital equipment industries. Most
recently, Mr. Lucia served as Director of Operations for Lorad, a subsidiary
of Hologic Corporation, where he directed manufacturing operations. Prior
to Hologic, Mr. Lucia served in a variety of executive positions with
several industry-leading firms, including Westinghouse. Sal holds a BA
in Economics from Clemson University and is past president and current
board member of NAPM (National Association of Purchasing Management),
Seven Counties Affiliate. Sal has responsibility for all manufacturing
activities of the ComfortScan system in the United States and abroad.
DOBI Medicals first application of the technology is the ComfortScan system, a non-invasive, non-ionizing, and pain-free optical imaging system designed to assist physicians in the improved detection of breast cancer. The ComfortScan system is intended to achieve this by providing new, physiology-based imagery of vascular changes in the breast which are not readily available today.
Cautionary Statement Regarding Forward-Looking
For further information:
DOBI Medical International